🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Well done & thank you to Dr Peta Lonski who led this project.👏 Peta is a super talented member of our #radphys team Peter Mac Radiation Oncology & a truly fabulous colleague. So thankful to work with you, petalonski! ⭐️ #womenwhocurie Peter Mac Cancer Centre JMIRO Journal Women in Lymphoma - [email protected] Michael MacManus

In the TARGET-TP RCT of biomarker driven thromboprophylaxis for adults w/cancer, thromboembolism (8% vs 23%) & death (13% vs 26%) were substantially reduced among those w/high-risk biomarker profiles receiving enoxaparin vs no thromboprophylaxis. ja.ma/3roEewG

Could a spike in ctDNA after the first fraction of radiotherapy in lung cancer be of prognostic significance? RadOncResearch Shankar Siva Stephen Wong Gerry Hanna Drew Moghanaki ctro.science/article/S2405-…

Great performance by Ireland in the Rugby! amp.theguardian.com/sport/2023/sep…

Congrats to Dr Mary Xu for her excellent work! Favourable outcomes from active surveillance of asymptomatic RT-induced meningiomas in #childhoodcancer #survivors. Free access to 19 Nov, thanks to @RadiotherapyOn1 🙏 authors.elsevier.com/c/1hrOscA0-I6Ft Peter Mac Cancer Centre RANZCR Sandro Porceddu

✨From our latest issue✨ 📢Lung shielding blocks significantly reduced mean lung doses in patients undergoing total body irradiation for haematological malignancies petalonski Michael MacManus Belinda Campbell et al ow.ly/s8a850PSIW5

Where in the world could you find such a beautiful and uncrowded tropical beach as Port Douglas?

Cute swimming pool visitor in Port Douglas QLD

My bet is we need smarter #RT...immunotherapy can only go so far if the #NSCLC #radonc is shutting down the immune system....time to think of new ways to skin this old cat...Michael MacManus Gerry Hanna Sue Yom Prof Tom John harry

Our phenomenal #radonc team!! A superbly productive and energising day of aspirations and strategic planning Peter Mac Radiation Oncology #thefutureisbright 😎 Peter Mac Cancer Centre Sandro Porceddu

In this new article from Michael MacManus, Dose-response relationships between radiation exposure, bone marrow function as measured by 18F-FLT PET, and lymphocyte counts during chemoradiation for non-small cell lung cancer. Read here in the #RedJournal: tinyurl.com/mcmanusred

Great discussion at #WCLC24 by Dr Chee Lee of really exciting early phase data from studies of 2 new TKIs with activity in HER2 mutant NSCLC. High response rates and acceptable toxicity.

Great presentation by RadOncResearch at the presidential session at #wclc2025 Compelling case for following best practice in lung cancer radiotherapy in clinical trials of radiation and systemic therapies. Timely staging and RT planning with PET, concurrent chemo and RT QA critical.

Terrific session on multimodality therapy in NSCLC at #wclc2024 Tantalising signals on potential role of induction chemoimmunotherapy before ChemoRT and even chemoimmunoRT before surgery. Thanks to discussant Gerry Hanna for bringing clarity to a complex set of abstracts!

Our congrats to Dr Fiona Hegi-Johnson, recipient of the George Hodgson Memorial Award.👏👏👏 Supported by the Peter MacCallum Cancer Foundation, the award funds a #radonc /radiobiol researcher Peter Mac Cancer Centre to attend the Lorne Cancer Conference. RadOncResearch Peter Mac Cancer Centre Peter Mac Research

Amazing data on KV minibeam treatments at Mayo Clinic presented at MMND-ITRO in Sydney. Fantastic local and abscopal responses in patients with highly resistant tumours! Encouraging for pursuing MRT research at Australian Synchrotron! Australian Synchrotron Mayo Clinic Peter Mac Radiation Oncology

Check this out! 😃 Clinical-research #fellowships in radiation oncology at Peter Mac Cancer Centre 🇦🇺 Apply here ➡️ careers.petermac.org/job/MELBOURNE-…